| 
            ITF 
			clears Lepchenko following meldonium explanation 
			
		 
		Send a link to a friend  
 
			
			
			 [September 21, 2016] 
			(Reuters) - American Varvara 
			Lepchenko is clear to play again after she was found to shoulder "no 
			fault or negligence" for an anti-doping rule violation, the 
			International Tennis Federation (ITF) said on Tuesday. 
			 
			The world number 79 tested positive for banned substance meldonium, 
			added to the World Anti Doping Agency's (WADA) prohibited list on 
			Jan. 1, during an in-competition test at the 2016 Brisbane 
			International, and on three subsequent occasions. 
			 
			The Uzbekistan-born player was provisionally suspended in March but 
			successfully appealed against her ban on the grounds that the 
			meldonium traces came from tablets she stopped taking "on or around 
			20 December 2015". 
			 
			The ITF, on the advice from WADA, said Lepchenko's samples were 
			consistent with her account. 
			 
			"It was accepted by the ITF that Lepchenko bore no fault or 
			negligence for the violation and that any period of ineligibility 
			that may otherwise have been imposed is eliminated entirely...," the 
			ITF said in a statement. 
			
			
			  
			"The results that Lepchenko obtained at the 2016 Brisbane 
			International event are automatically disqualified..., and the 
			points and prize money that she won are forfeit." 
			 
			"This presence violation will be disregarded for sanctioning 
			purposes in the event that Lepchenko commits any further anti-doping 
			rule violation." 
			 
			
            [to top of second column]  | 
            
             
            
			  
            
			Varvara Lepchenko of the United States hits a forehand against Ana 
			Konjuh of Croatia (not pictured) on day six of the 2016 U.S. Open 
			tennis tournament at USTA Billie Jean King National Tennis Center. 
			Geoff Burke-USA TODAY Sports 
            
			  
			Russian five-times grand slam champion and former world number one 
			Maria Sharapova is the sport's highest-profile athlete to be banned 
			after testing positive for meldonium, a drug designed for heart 
			conditions that increases blood flow. 
			
			The Court of Arbitration for Sport (CAS) is set to rule on 
			Sharapova's appeal against a two-year ban in the first week of next 
			month. 
			 
			(Reporting by Nivedita Shankar in Bengaluru; Editing by John 
			O'Brien) 
			
			[© 2016 Thomson Reuters. All rights 
			reserved.] 
			Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  |